|
| New insights in melanoma resistance to BRAF inhibitors: a role for microRNAs |
|
https://doi.org/10.18632/oncotarget.26244
Marta DÃaz-MartÃnez, LucÃa Benito-Jardón, and Joaquin Teixidó
|
| 35374-35375 |
|
| Targeting agerelated inflammation in myelodysplastic syndromes |
|
https://doi.org/10.18632/oncotarget.26266
Yang Mei, and Peng Ji
|
| 35376-35377 |
|
| NOX2 oxidase expressed in endosomes promotes cell proliferation and prostate tumour development |
|
https://doi.org/10.18632/oncotarget.26237
Ian P. Harrison, Antony Vinh, Ian R.D. Johnson, Raymond Luong, Grant R. Drummond, Christopher G. Sobey, Tony Tiganis, Elizabeth D. Williams, John J. O’Leary, Doug A. Brooks, and Stavros Selemidis
|
| 35378-35393 |
|
| Personalized identification of tumorassociated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment |
|
https://doi.org/10.18632/oncotarget.26247
Sindy Vrecko, David Guenat, Patricia Mercier-Letondal, Hugues Faucheu, Magalie Dosset, Bernard Royer, Jeanne Galaine, Romain Boidot, Stefano Kim, Marine Jary, Olivier Adotévi, Christophe Borg, and Yann Godet
|
| 35394-35407 |
|
| Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors |
|
https://doi.org/10.18632/oncotarget.26253
Xuguang Zhu, Erik Holmsen, Sunmi Park, Mark C. Willingham, Jun Qi, and Sheue-yann Cheng
|
| 35408-35421 |
|
| The adaptive regulation of thiamine pyrophosphokinase1 facilitates malignant growth during supplemental thiamine conditions |
|
https://doi.org/10.18632/oncotarget.26259
Hunter C. Jonus, Bradley S. Hanberry, Shivani Khatu, Jaeah Kim, Hendrik Luesch, Long H. Dang, Michael G. Bartlett, and Jason A. Zastre
|
| 35422-35438 |
|
| Systematic review and metaanalysis of thirdline salvage therapy for the treatment of advanced nonsmallcell lung cancer: A metaanalysis of randomized controlled trials |
|
https://doi.org/10.18632/oncotarget.24967
Nan Zhang, Nan Guo, Liang Tian, and Zhigang Miao
|
| 35439-35447 |
|
| Naturally occurring compounds as pancreatic cancer therapeutics |
|
https://doi.org/10.18632/oncotarget.26234
Ines Lohse, Erin Wildermuth, and Shaun P. Brothers
|
| 35448-35457 |
|
| Constitutional mismatch repairdeficiency: current problems and emerging therapeutic strategies |
|
https://doi.org/10.18632/oncotarget.26249
Malak Abedalthagafi
|
| 35458-35469 |
